| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $4K | +1473.0% |
| R&D Expense | $996K | +8.8% |
| SG&A Expense | $2.7M | -11.0% |
| Operating Income | -$3.7M | +7.8% |
| Net Income | -$3.4M | +13.4% |
| EPS (Basic) | -$1.92 | +52.0% |
| EPS (Diluted) | -$1.92 | +52.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $8 | +0.0% |
| Current Assets | $16.8M | +362.0% |
| Total Assets | $17.0M | +360.6% |
| Current Liabilities | $402K | +48.7% |
| Total Liabilities | $402K | +48.7% |
| Stockholders' Equity | $16.6M | +385.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.3M | -10.1% |
| Investing Cash Flow | $68K | +102.7% |
| Financing Cash Flow | $16.6M | +183.1% |